-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Repeats as One of Shijiazhuang’s Top 100 Enterprises
Category:
发布时间：2024-09-30
【概要描述】
To mark the 75th anniversary of the founding of the People’s Republic of China, the Shijiazhuang Federation of Enterprises and the Shijiazhuang Entrepreneurs Association jointly hosted the 2024 Shijiazhuang Entrepreneurs’ Day Celebration on September 29. During the event, the “Letter to All Entrepreneurs in Shijiazhuang” issued by the CPC Shijiazhuang Municipal Committee and the Shijiazhuang Municipal People’s Government was read aloud, and the 2024 rankings of the top 100 enterprises in Shijiazhuang by operating revenue, technological innovation, and tax contributions, along with a catalog of renowned and high-quality products, were unveiled.
On the occasion of the 75th anniversary of the founding of the People’s Republic of China, the Shijiazhuang Enterprise Federation and the Shijiazhuang Entrepreneurs Association jointly hosted the 2024 Shijiazhuang Entrepreneurs’ Day Celebration on September 29. During the event, the “Letter to All Entrepreneurs in the City” issued by the CPC Shijiazhuang Municipal Committee and the Shijiazhuang Municipal People’s Government was read aloud, and the 2024 rankings of the top 100 enterprises in Shijiazhuang in terms of operating revenue, technological innovation, and tax contributions, along with a catalog of renowned and high-quality products, were unveiled.
The Group has once again ranked among the Top 100 enterprises in Shijiazhuang for operating revenue, technological innovation, and tax payments, placing 19th in operating revenue, 11th in technological innovation, 26th in tax payments for Shijiazhuang Sihua Pharmaceutical, and 66th for the Shijiazhuang Sihua Pharmaceutical Development Zone Branch. In addition, several of the Group’s products, including azithromycin, hydroxyethyl starch, and buxanserin from Guolong Pharmaceutical, have been included in the Catalogue of Famous and High-Quality Products.
Over the past 76 years, the Group has weathered countless challenges and emerged stronger, evolving into a large, integrated pharmaceutical conglomerate that pursues diversified, synergistic development across innovative medicines, specialty generic drugs, active pharmaceutical ingredients, and pharmaceutical packaging materials. It is a key pillar enterprise in Shijiazhuang’s biopharmaceutical industry, a leading domestic player in the R&D, manufacturing, and export of chemical injectable formulations, and has been recognized as one of China’s Top 100 Pharmaceutical Companies (ranked 51st in 2023), among the Top 20 Chinese companies in chemical drug R&D, a National Model Enterprise for Technological Innovation, a National Single-Champion Enterprise in Manufacturing, and a recipient of the Provincial Quality Award. The Group’s scale and brand influence have grown substantially, making significant contributions to national and local economic and social development.
With renewed vigor and determination, we set sail on a new journey, for now is the time to achieve remarkable accomplishments and make lasting contributions. The conference calls on entrepreneurs across the board to further strengthen their awareness of reform, seize policy-driven opportunities, embrace the new mission of driving innovation and reform and leading the way, assume the new responsibility of confronting challenges head-on and breaking through obstacles, continuously enhance their capacity for innovation and competitiveness, and once again deliver outstanding results in advancing high-quality development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091